In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ProQinase GmbH

Latest From ProQinase GmbH

ProQinase GMBH

ProQinase GMBH was established as a wholly owned subsidiary of the Tumor Biology Centre (TBC), Freiburg, in April 2001 to commercialize the centre's research on protein kinases. During their years of basic research at TBC, ProQinase's scientists have developed extensive know-how in the protein kinase arena and have established a range of tools and assays to identify, produce, manipulate and screen protein kinases' activities. These tools and assays now constitute the Integrated Technology Platform Protein Kinases that ProQinase is commercializing through a hybrid business model. The company will apply the platform technology to its own in-house drug discovery and development activities and also make it available to external clients on a fee-for-service basis.
BioPharmaceutical Europe

Recent Dealmaking (7/2003)

Summarizing the month in European dealmaking.

Recent Dealmaking (06/2003)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • ProQinase GmbH
  • Senior Management
  • Arno Fritzen, Dir., Fin. & Admin.
    Michael Kubbatat, Dir., R&D
  • Contact Info
  • ProQinase GmbH
    Phone: (49) 761 206 1780
    Breisacher Str. 117
    Freiburg, 79106